IRCCS Ospedale San Raffaele
Milan, 20132, Italy
NCT Number: NCT05774769
Mitral regurgitation (MR) for degenerative disease is nowadays routinely treated with valve repair with excellent short and long term results in experienced centers. However, repair durability can varies according to the characteristics of the initial lesion, and better long term durability in isolated lesions of the posterior leaflets compared to anterior or bi-leaflets prolapse has been shown. A commissural MR can be caused by lesions of the anterior, posterior or both leaflets and several surgical techniques have been proposed to treat these lesions. However, long term outcomes of mitral valve repair (MVr) for isolated commissural flail or prolapse remain poor defined. In San Raffaele Hospital cardiac surgery, commissural lesions are usually treated with a functional approach, by means of edge-to-edge approximation of the anterior and posterior leaflet at the commissural area (commissural closure). The investigators previously reported the short and mid-term outcomes of this technique with satisfactory results. With this study the investigators aim to analyze the very long term clinical and echocardiographic results of isolated commissural lesions treated with commissural closure.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Milan, 20132, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Edge to edge is the suture of mitral valve leaflets tissue in the regurgitant spot. If the regurgitant jet is near a mitral commissure, it is called a commissural edge to edge.
Time frame: Through study completion, an average of 14,5 years
Michele De Bonis
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04281940
Cardiovascular Diseases, Degenerative Mitral Valve Disease
Tbilisi, Georgia
View Trial DetailsNCT05839782
Degenerative Mitral Valve Disease
Milan, Italy
View Trial DetailsNCT05836532
Cardiovascular Diseases, Degenerative Mitral Valve Disease
Milan, Italy
View Trial DetailsNCT03433274
Cardiovascular Diseases, Degenerative Mitral Valve Disease
Birmingham, Alabama, United States
View Trial Details